RecruitingNCT06834178

Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria

Hepatitis Elimination And Liver Care in South-East Austria (HEAL-S)

Sponsor

Vanessa Stadlbauer-Koellner, MD

Enrollment

100 participants

Start Date

May 1, 2025

Study Type

OBSERVATIONAL

Conditions

Hepatitis B HBV HCV HDV Coinfection Hepatitis B Coinfection

Summary

The HEAL-S study is a non-interventional study with retrospective data analysis. It consists of two parts. First a retrospective analysis based on nucleic acid testing (NAT) results will be performed. Two cohorts (HCV) and (HBV) will be established. Patients falling into one (or both) of the two cohorts will be invited to a prospective linkage-to-care study. In this part, patients are invited to the clinic, where the possibility of hepatitis treatment will be discussed.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with coinfection, hbv, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.